Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Oxycodone
(D05312)
[1] Oxycodone[3] Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone (D05312) 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[2] 46, 298 💬
2Oxycodone depot ”sandoz”, depot tablets
(D05312)
[1] Oxycodone[3] Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone (D05312) 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 298 💬
3Oxycodone hydrochloride
(D05312)
[1] Oxycodone[3] Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone (D05312) 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[4] 6, 70, 226, 298 💬
4Oxycodone naloxone prolonged release tablets
(D05312)
[1] Oxycodone[3] Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone (D05312) 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
5Oxycodone orion
(D05312)
[1] Oxycodone[3] Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone (D05312) 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 70 💬
6Oxycodone/acetaminophen
(D05312)
[1] Oxycodone[3] Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone (D05312) 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 231 💬
7Oxycodone/naloxone prolonged release T
(D05312)
[2] Naloxone,
Oxycodone
[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone (D05312),
Naloxone ,
Naloxone hydrochloride dihydrate 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
8Oxycodone/naloxone prolonged release tablets
(D05312)
[1] Oxycodone[3] Oxycodone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone (D05312) 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬
9Oxycodone/naloxone prolonged release tablets 10 MG /5 MG
(D05312)
[2] Naloxone,
Oxycodone
[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone (D05312),
Naloxone ,
Naloxone hydrochloride dihydrate 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬
10Oxycodone/naloxone prolonged release tablets 10/5 MG
(D05312)
[2] Naloxone,
Oxycodone
[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone (D05312),
Naloxone ,
Naloxone hydrochloride dihydrate 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
11Oxycodone/naloxone prolonged release tablets 20 MG /10 MG
(D05312)
[2] Naloxone,
Oxycodone
[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone (D05312),
Naloxone ,
Naloxone hydrochloride dihydrate 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬
12Oxycodone/naloxone prolonged release tablets 20/10 MG
(D05312)
[2] Naloxone,
Oxycodone
[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone (D05312),
Naloxone ,
Naloxone hydrochloride dihydrate 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
13Oxycodone/naloxone prolonged release tablets 5 MG /2.5 MG
(D05312)
[2] Naloxone,
Oxycodone
[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone (D05312),
Naloxone ,
Naloxone hydrochloride dihydrate 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 6 💬
14Oxycodone/naloxone prolonged release tablets 5/2.5 MG
(D05312)
[2] Naloxone,
Oxycodone
[6] Oxycodone hydrochloride ,
Naloxone hydrochloride ,
Oxycodone terephthalate ,
Oxycodone (D05312),
Naloxone ,
Naloxone hydrochloride dihydrate 💬
[3] OPRD1,
OPRK1,
OPRM1 💬
[7] Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226 💬
15PR oxycodone
(D05312)
----[1] 6 💬